Cafiero, C.; Palmirotta, R.; Martinelli, C.; Micera, A.; Giacò, L.; Persiani, F.; Morrione, A.; Pastore, C.; Nisi, C.; Modoni, G.;
et al. Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients. Genes 2025, 16, 265.
https://doi.org/10.3390/genes16030265
AMA Style
Cafiero C, Palmirotta R, Martinelli C, Micera A, Giacò L, Persiani F, Morrione A, Pastore C, Nisi C, Modoni G,
et al. Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients. Genes. 2025; 16(3):265.
https://doi.org/10.3390/genes16030265
Chicago/Turabian Style
Cafiero, Concetta, Raffaele Palmirotta, Canio Martinelli, Alessandra Micera, Luciano Giacò, Federica Persiani, Andrea Morrione, Cosimo Pastore, Claudia Nisi, Gabriella Modoni,
and et al. 2025. "Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients" Genes 16, no. 3: 265.
https://doi.org/10.3390/genes16030265
APA Style
Cafiero, C., Palmirotta, R., Martinelli, C., Micera, A., Giacò, L., Persiani, F., Morrione, A., Pastore, C., Nisi, C., Modoni, G., Galeano, T., Guarino, T., Foggetti, I., Nisticò, C., Giordano, A., & Pisconti, S.
(2025). Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients. Genes, 16(3), 265.
https://doi.org/10.3390/genes16030265